TTK Healthcare Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 2.23% vs 11.36% in Dec 2024

Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is -37.06% vs 29.79% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -7.15% vs 44.01% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -17.07% vs 256.52% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of TTK Healthcare With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

209.30

629.92

-420.62

-66.77%

Other Operating Income

0.00

Total Operating income

209.30

629.92

-420.62

-66.77%

Raw Material Cost

51.38

402.85

-351.47

-87.25%

Purchase of Finished goods

53.96

5.83

48.13

825.56%

(Increase) / Decrease In Stocks

-7.72

2.46

-10.18

-413.82%

Employee Cost

41.73

65.90

-24.17

-36.68%

Power Cost

0.00

Manufacturing Expenses

0.00

-0.01

0.01

100.00%

Selling and Distribution Expenses

0.00

Other Expenses

62.81

87.47

-24.66

-28.19%

Total Expenditure (Excl Depreciation)

202.16

564.50

-362.34

-64.19%

Operating Profit (PBDIT) excl Other Income

7.14

65.42

-58.28

-89.09%

Other Income

17.43

17.56

-0.13

-0.74%

Operating Profit (PBDIT)

24.57

82.98

-58.41

-70.39%

Interest

0.68

5.00

-4.32

-86.40%

Exceptional Items

-7.58

0.00

-7.58

Gross Profit (PBDT)

16.31

77.98

-61.67

-79.08%

Depreciation

2.22

12.48

-10.26

-82.21%

Profit Before Tax

14.09

65.50

-51.41

-78.49%

Tax

3.55

17.02

-13.47

-79.14%

Provisions and contingencies

0.00

Profit After Tax

10.53

48.48

-37.95

-78.28%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

10.53

48.48

-37.95

-78.28%

Equity Capital

14.13

171.00

-156.87

-91.74%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

7.45

2.84

4.61

162.32%

Diluted Earnings per share

7.45

2.83

4.62

163.25%

Operating Profit Margin (Excl OI)

3.41%

10.39%

0.00

-6.98%

Gross Profit Margin

7.79%

12.38%

0.00

-4.59%

PAT Margin

5.03%

7.70%

0.00

-2.67%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 209.30 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 2.81% vs -10.10% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 2.23% vs 11.36% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 10.53 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -48.36% vs 56.85% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -37.06% vs 29.79% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 7.14 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 33.96% vs 98.88% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -7.15% vs 44.01% in Dec 2024

Quarterly - Interest

Interest 0.68 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -19.05% vs 9.09% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -17.07% vs 256.52% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 3.41%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024